Open Actively Recruiting

A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)

About

Brief Summary
Primary Purpose
Treatment
Study Type
Interventional
Phase
Phase 2

Eligibility

Gender
Male
Healthy Volunteers
No
Minimum Age
4 Years
Maximum Age
9 Years

Key Common Inclusion Criteria:

Key Common Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
22-5128
Category
Genetic and Rare Diseases
Musculoskeletal Disorders
Pediatric and Prenatal Disorders
Contact
Andres Vargas Gonzalez
Location
  • UCLA Westwood
For Providers
NCT No.
NCT05540860
For detailed technical eligibility, visit ClinicalTrials.gov.